FDA Restricts J&J's COVID-19 Vaccine Due To Blood Clot Risk

The FDA has restricted the use of the J&J COVID vaccine due to the risk of rare but serious blood clots. The vaccine should only be given to adults who cannot receive other vaccines or specifically request it. US authorities recommend using Pfizer or Moderna vaccines instead. This decision follows a review of data on life-threatening clots.

What is the main reason the FDA recommends limiting the use of the J&J vaccine?

• It requires special storage conditions.

• It has a risk of causing rare but serious blood clots.

• It is more expensive than other vaccines.

• It is less effective than other vaccines.

Who should consider receiving the J&J vaccine according to the FDA?

• People who have already had COVID-19.

• Adults who cannot receive other vaccines or specifically request it.

• Children under 12 years old.

• Anyone who prefers a single-dose vaccine.

Which vaccines are recommended by US authorities for starting COVID vaccinations?

• AstraZeneca or Sputnik V

• Pfizer or Moderna

• Sinovac or Sinopharm

• Covaxin or Covovax

What prompted the FDA to restrict the J&J vaccine?

• A new study on vaccine efficacy.

• A review of data on life-threatening clots.

• A shortage of vaccine supply.

• Public demand for alternative vaccines.

What is the FDA's stance on the J&J vaccine after reviewing the data?

• They have approved it for all age groups.

• They have restricted its use due to clot risks.

• They have recommended it as the primary vaccine.

• They have discontinued its use entirely.